WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed the sale of BPD Healthcare (“BPD” or the “Company”) to MJH Life Sciences (“MJH”), the largest privately held medical media company in North America. MJH Life Sciences is dedicated to improving patient care through trusted health care communications, […]
— REMAIN results showed sustained, 3-line vision gains vs baseline through 152 weeks for MCO-010 in patients having severe vision loss from retinitis pigmentosa, and a favorable safety profile — The data form the clinical basis of a rolling Biologics License Application, initiated in June 2025, with the potential to be the first FDA-approved optogenetic
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or "the Company") (NASDAQ:LFMD) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants
The wellness visionary announces a global initiative to empower women leaders, reframing health as a leadership strategy. Lizanne Falsetto, founder of thinkThin®and longtime advocate for women's wellness, today announced the launch of a global Women's Wellness Movement: an initiative designed to empower women leaders to take ownership of their health, share knowledge transparently, and close
LOS ANGELES, Oct. 22, 2025 (GLOBE NEWSWIRE) — Today, Vema Hydrogen, developer of a disruptive renewable hydrogen production technology – Engineered Mineral Hydrogen(TM) – announced that it has been chosen as a Qualified Supplier by The First Public Hydrogen Authority (FPH2). The collaboration positions Vema to supply clean hydrogen at scale to California's municipalities, transit
(NasdaqGM:GRTX), Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera's dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) an upfront payment of $3.5 million, 2) potential future regulatory milestones, commercial milestones, and contingent value rights of up to $105 million. Biossil assumes all further
(Other OTC:HGRAF),(CNSX:HG.CN),(NASDAQ:GOSS),(NASDAQ:NVA),(AUST:NVA.AX),(AUST:NVA),(Other OTC:UARI),(TSX-V:WLR),(Other OTC:SGGTF),(TSX-V:SGU),(Other OTC:FRSPF),(CNSX:PHOS.CN),(Other OTC:LGCXF),(TSX-V:LG),(Other OTC:RGBP),(Other OTC:SRGZ),(NASDAQ:CLNN),(PinkSheets:CMCXF),(Other OTC:ELRRF),(TSX:ELO),(AUST:IBX),(AUST:IBX.AX),(AUST:IBX.XA), MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) — EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 87th Emerging Growth Conference on October 22 & 23, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management
Oakland, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — At a time when AI is transforming every industry, most organizations are pouring significant resources into AI. Yet widespread adoption often stalls and successes have been limited, leaving leaders to wonder: “Is my company truly ready for AI?” Surveys from McKinsey, Deloitte, and Gallup show the gap
(NASDAQ:AVIR), BOSTON, Oct. 22, 2025 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a virtual key opinion leader (KOL) event on Thursday, November 13, 2025 at 10:00 AM
(NasdaqGM:FDBC), DUNMORE, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary, The Fidelity Deposit and Discount Bank, announced its unaudited, consolidated financial results for the three- and nine-month periods ended September 30, 2025. Unaudited Financial Information Net income for the quarter ended September 30, 2025